236 related articles for article (PubMed ID: 16859738)
1. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
2. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
[TBL] [Abstract][Full Text] [Related]
3. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
[TBL] [Abstract][Full Text] [Related]
5. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
6. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
Sayer RA; Lancaster JM; Pittman J; Gray J; Whitaker R; Marks JR; Berchuck A
Gynecol Oncol; 2005 Feb; 96(2):355-61. PubMed ID: 15661221
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
8. IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.
Qian B; Katsaros D; Lu L; Canuto EM; Benedetto C; Beeghly-Fadiel A; Yu H
Oncol Rep; 2011 Jan; 25(1):203-13. PubMed ID: 21109978
[TBL] [Abstract][Full Text] [Related]
9. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
[TBL] [Abstract][Full Text] [Related]
10. IGF-II promoter methylation and ovarian cancer prognosis.
Beeghly AC; Katsaros D; Wiley AL; Rigault de la Longrais IA; Prescott AT; Chen H; Puopolo M; Rutherford TJ; Yu H
J Cancer Res Clin Oncol; 2007 Oct; 133(10):713-23. PubMed ID: 17569086
[TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
12. [Expression and prognostic significance in epithelial ovarian cancer].
Katsaros D; Yu H; Piccinno R; Puopolo M; Rigault De La Longrais IA; Fracchioli S; Massobrio M
Minerva Ginecol; 2002 Feb; 54(1):15-24. PubMed ID: 11828267
[TBL] [Abstract][Full Text] [Related]
13. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
14. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
17. IGF-I in epithelial ovarian cancer and its role in disease progression.
Brokaw J; Katsaros D; Wiley A; Lu L; Su D; Sochirca O; de la Longrais IA; Mayne S; Risch H; Yu H
Growth Factors; 2007 Oct; 25(5):346-54. PubMed ID: 18236213
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
19. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.
Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H
Gynecol Oncol; 2004 Sep; 94(3):685-92. PubMed ID: 15350359
[TBL] [Abstract][Full Text] [Related]
20. Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.
Mineo R; Fichera E; Liang SJ; Fujita-Yamaguchi Y
Biochem Biophys Res Commun; 2000 Feb; 268(3):886-92. PubMed ID: 10679300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
